ResMed
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $1,347,993 | $1,291,736 | $1,282,089 | $1,224,509 |
Gross Profit | 820,070 | 766,408 | 751,275 | 717,219 |
EBITDA | 532,341 | 469,603 | 479,012 | 442,709 |
EBIT | 458,053 | 417,693 | 423,110 | 388,999 |
Net Income | 379,705 | 365,041 | 344,622 | 311,355 |
Net Change In Cash | 1,347,993 | 1,291,736 | 1,282,089 | 1,224,509 |
Free Cash Flow | 508,181 | 554,873 | 289,746 | 305,931 |
Cash | 1,209,450 | 932,711 | 521,944 | 426,361 |
Basic Shares | 147,037 | 147,220 | 147,599 | 147,599 |
Annual Financials
| Values in thousands | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
Revenue | $5,146,327 | $4,685,297 | $4,222,993 | $3,578,127 |
Gross Profit | 3,054,970 | 2,655,303 | 2,355,662 | 2,024,311 |
EBITDA | 1,913,377 | 1,533,543 | 1,358,801 | 1,176,636 |
EBIT | 1,677,566 | 1,317,334 | 1,162,279 | 982,795 |
Net Income | 1,400,723 | 1,020,951 | 897,556 | 779,437 |
Net Change In Cash | 5,146,327 | 4,685,297 | 4,222,993 | 3,578,127 |
Free Cash Flow | 1,661,723 | 1,286,404 | 559,299 | 195,111 |
Cash | 1,209,450 | 238,361 | 227,891 | 273,710 |
Basic Shares | 147,340 | 147,550 | 147,455 | 147,043 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | $2.55 |
2025-03-31 | $2.37 |
2024-12-31 | $2.43 |
2024-09-30 | $2.20 |
